Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)

Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)

US Patent 12134790 · Granted Nov 5, 2024

Estimated economic value: $3,718,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-ALK2 antibodies and uses thereof2025
Composition and methods for treatment of ornithine transcarbamylase deficiency2025
Methods of treating tissue calcification2023
Methods of treating tissue calcification2023
Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated2022
Methods of treating myointimal proliferation2022
Methods of treating myointimal proliferation2022
Treating seizure with recombinant alkaline phosphatase2022
Treating muscle weakness with alkaline phosphatases2021
Composition and methods for treatment of ornithine transcarbamylase deficiency2021
Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated2020
Methods of treating tissue calcification2019